ConductScience.org, home

Paper25154392

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.

Risbridger GP and 16 others. Eur Urol, 2015. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. Papers, record 25154392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25154392

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
PubMed
Journal
Eur Urol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
3.08
iCite
Revised in PubMed
2015-03-12
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Risbridger GPGail P
2Taylor RARenea A
3Clouston DDavid
4Sliwinski AAnia
5Thorne HHeather
6Hunter SSally
7Li JJason
8Mitchell GGillian
9Murphy DDeclan
10Frydenberg MMark
11Pook DDavid
12Pedersen JJohn
13Toivanen RRoxanne
14Wang HHong
15Papargiris MMelissa
16Lawrence MGMitchell G
17Bolton DMDamien M

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BRCA2 ProteinMajor topic
Carcinoma, Intraductal, NoninfiltratingMajor topic
MutationMajor topic
Prostatic NeoplasmsMajor topic
Aged
Animals
Genetic Predisposition to Disease
Heredity
Heterografts
Humans
Incidence
Kaplan-Meier Estimate
Male
Mice, Inbred NOD
Mice, SCID
Middle Aged
Neoplasm Transplantation
Pedigree
Phenotype
Proportional Hazards Models
Prostatectomy
Risk Factors
Time Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in25194910A better understating of the morphological features and molecular characteristics of intraductal carcinoma helps clinicians further explain prostate cancer aggressiveness.https://conductscience.org/library/papers/25194910

Source PubMed

Download CSV of comments and corrections

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
42897296Rare prostate cancer histologies: detection, characteristics and treatment.Nat Rev Urol2026https://conductscience.org/library/papers/42897296PubMed
42855542Cribriform and intraductal carcinoma in prostate cancer - implications for risk stratification and therapeutic decision-making.Nat Rev Urol2026https://conductscience.org/library/papers/42855542PubMed
42806037Clinical and MRI characteristics of germline pathogenic variant carriers diagnosed with prostate cancer.Eur Radiol2026https://conductscience.org/library/papers/42806037PubMed
40452312Intraductal carcinoma of the prostate: A comprehensive literature review focused on grading challenges and controversies.Histol Histopathol2025https://conductscience.org/library/papers/40452312PubMed
39937427Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P.Int J Clin Oncol2025https://conductscience.org/library/papers/39937427PubMed
39840193Genetic Analysis of Intraductal Carcinoma of the Prostate Detected in High-Grade Prostatic Intraepithelial Neoplasia Cases.Cureus2024https://conductscience.org/library/papers/39840193PubMed
39465570Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P) in determining abiraterone efficacy for metastatic hormone-sensitive prostate cancer (mHSPC) patients.Prostate2025https://conductscience.org/library/papers/39465570PubMed
39254403Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.Asian J Androl2024https://conductscience.org/library/papers/39254403PubMed
38893122Cribriform versus Intraductal: How to Determine the Difference.Cancers (Basel)2024https://conductscience.org/library/papers/38893122PubMed
38736618Cribiform and intraductal carcinoma in hereditary prostate cancer: clinical and pathological analysis of 20 cases.Am J Clin Exp Urol2024https://conductscience.org/library/papers/38736618PubMed
38732035Unveiling the Genomic Landscape of Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis.Int J Mol Sci2024https://conductscience.org/library/papers/38732035PubMed
38539432Intraductal Carcinoma of the Prostate versus Simulants: A Differential Diagnosis Growing in Clinical Impact.Cancers (Basel)2024https://conductscience.org/library/papers/38539432PubMed
38417222Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations.Neoplasia2024https://conductscience.org/library/papers/38417222PubMed
38379333Molecular complexity of intraductal carcinoma of the prostate.Cancer Med2024https://conductscience.org/library/papers/38379333PubMed
38339274Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review.Cancers (Basel)2024https://conductscience.org/library/papers/38339274PubMed
38067216Molecular Alterations in Intraductal Carcinoma of the Prostate.Cancers (Basel)2023https://conductscience.org/library/papers/38067216PubMed
37732318Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer.Front Genet2023https://conductscience.org/library/papers/37732318PubMed
37511177DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology.Int J Mol Sci2023https://conductscience.org/library/papers/37511177PubMed
37408208Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications.Cells2023https://conductscience.org/library/papers/37408208PubMed
37307876Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.Mod Pathol2023https://conductscience.org/library/papers/37307876PubMed

See all 69 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25154392

GET https://conductscience.org/api/papers/v1/25154392/cited_by?page=2